Abstract:Objective The investigation aimed at producing transgenic mouse model with myocardium-specific overex-pression of human KCNE4 (hKCNE4) gene so as to research into the prophylactic and therapeutic effect of hKCNE4 gene on a certain subset of atrial fibrillation. Methods hKCNE 4 gene was cloned by reverse transcription-polymerase chain reaction (RT-PCR), digested with restrictive endonuclease, and inserted into the cardiomyocyte-specific expressing plasmidα-MHC-Clone 26 by ligase. Enzymatic and sequencing analyses were performed to confirm hKCNE4-α-MHC-Clone 26 prior to obtaining the BamHI treated transgenic element hKCNE4-α-MHC-hGH pA. The hKCNE4-α-MHC-hGH pA was microinjected into the male pronucleus of fertilized oocyte of C57BL mice and the oocytes surviving microin-jection were transplanted into the oviducts of pseudo-pregnant mice. The positive transgenic founder (G0 generation) mice were identified by PCR from offspring generated by pseudo-pregnant mice. The G0 transgenic mice were mated respectively with wild-type C57BL mice to reproduce G1 transgenic progeny. RT-PCR and sequencing were applied to screening for transgenic mice expressing hKCNE4 from G1 transgenic descendants. Results hKCNE4 gene was cloned and ligated to the vectorα-MHC-Clone 26 correctly. 86 mice were generated 9 of which were identified to be transgenic and the trans-gene hKCNE 4 carried by 2 transgenic mice (titled as Line A and Line B respectively) was not only transmitted to the next generation but also overexpressed restrictedly in the hearts. Preliminary phenotypic analysis on the transgenic progeny of Line A and Line B showed that they developed normally, reproduced generally, and suffered from no arrhythmia documented by surface electrocardiography. Conclusion The results indicate that the transgenic mice cardiomyocyte-specifically overexpressing hKCNE 4 are successfully procured, which provides a valuable tool for the exploration of the preventive and remedial influence of hKCNE 4 on a subgroup of atrial fibrillation.

Construction of ACTA2 mutation transgenic mice

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

[Construction and Expression of APP(SWE) Transgenic Mice Model].

Establishment of two cardiac-specific human cardiac troponin C mutation transgenic mice and comparative analysis

Establishment and identification of MTA1 transgenic mouse model

Establishment of the Conditional Tetracycline-Regulated Transgenic Mice Over-Expressing Mouse Platelet and T Cell Activation Antigen 1

[Cloning, expression and sequence analysis and tissue distribution of angiotensin-converting enzyme 2 (ACE2) gene in adult mice].

Construction of Transgene and Transgenic M Ice of Amyloid Precursor Protein Gene with Swedish Mutation

Construction and expression of HLA-DR(α), DRB1 * 0401 transgenic mice model

Establishment of transgenic mice which express SARS coronavirus functional receptor human ACE2

Establishment of Tetracycline-controlled A30P Mutation α-synuclein Transgenic Mice

Construction and eukaryotic expression of human antithrombin Cys248 site mutant

Generation of outbred Ace2 knockout mice by RNA transfection of TALENs displaying colitis reminiscent pathophysiology and inflammation

Construction of Mouse Annexin II Gene Knockout Recombinant and Generation of Mouse Annexin II-/- Cell Line

[Study on a Human Tissue-Type Plasminogen Activator Mutant Cdna Knocked-in the Beta-Casein Gene Site of Murine ES Cells].

[Establishment of a CMTM2 Transgenic Mouse Model and the Alteration of Its Serum Testosterone Level].

[Biological Characteristics of Cleft Palate Relevant Gene Thyroid Transcription Factor-2 Transgenic Mice].

Construction of Afp-cre-lacZ Transgenic Mouse Model

[The Establishment of Conditional MT Transgenic Mice Model].

The Construction of Eukaryotic Expression Vector of Mouse GATA4 and Its Expression in P19 Cells

Bioinformatic Analysis of TMEM66 Gene and Construction of TMEM66 Mutant Transgenic Mice